Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation
Status:
Completed
Trial end date:
2019-06-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Medroxyprogesterone Acetate (MPA)
administration in follicular phase prevents premature luteinization with equal efficiency as
GnRH antagonists and otains similar clinical results in oocyte donation.
Phase:
Phase 3
Details
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA